Published in Proc Natl Acad Sci U S A on June 06, 2000
Microarray expression profiling identifies genes with altered expression in HDL-deficient mice. Genome Res (2000) 4.95
Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Invest (2003) 2.76
Project normal: defining normal variance in mouse gene expression. Proc Natl Acad Sci U S A (2001) 2.66
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A (2001) 2.64
Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proc Natl Acad Sci U S A (2002) 2.32
Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells. Cardiovasc Res (2014) 2.25
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest (2001) 2.03
Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts. Proc Natl Acad Sci U S A (2002) 1.97
Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation (2011) 1.81
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene. Proc Natl Acad Sci U S A (2004) 1.21
Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol Res (2003) 1.19
Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol. Mol Cell Biol (2003) 1.15
FunnyBase: a systems level functional annotation of Fundulus ESTs for the analysis of gene expression. BMC Genomics (2004) 1.12
Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation (2012) 1.11
Regression of pressure-induced left ventricular hypertrophy is characterized by a distinct gene expression profile. J Thorac Cardiovasc Surg (2009) 1.09
Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart. PLoS One (2013) 1.09
RNA expression profiles and data mining of sugarcane response to low temperature. Plant Physiol (2003) 1.08
Gene program for cardiac cell survival induced by transient ischemia in conscious pigs. Proc Natl Acad Sci U S A (2001) 1.06
Increased susceptibility to isoproterenol-induced cardiac hypertrophy and impaired weight gain in mice lacking the histidine-rich calcium-binding protein. Mol Cell Biol (2006) 1.02
Structure, Expression, and Function of a Novel Intercalated Disc Protein, Xin. J Med Sci (2005) 1.00
Genome-wide analyses of gene expression during mouse endochondral ossification. PLoS One (2010) 0.98
GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets. PLoS One (2011) 0.95
Identification of a core set of genes that signifies pathways underlying cardiac hypertrophy. Comp Funct Genomics (2004) 0.92
Time-warped comparison of gene expression in adaptive and maladaptive cardiac hypertrophy. Circ Cardiovasc Genet (2009) 0.92
Recovery from decompensated heart failure is associated with a distinct, phase-dependent gene expression profile. J Surg Res (2012) 0.87
Functional annotation of mouse mutations in embryonic stem cells by use of expression profiling. Mamm Genome (2004) 0.84
Microarray analysis: a novel research tool for cardiovascular scientists and physicians. Heart (2003) 0.84
Calcium-mediated histone modifications regulate alternative splicing in cardiomyocytes. Proc Natl Acad Sci U S A (2014) 0.83
Up-regulation of alpha-smooth muscle actin in cardiomyocytes from non-hypertrophic and non-failing transgenic mouse hearts expressing N-terminal truncated cardiac troponin I. FEBS Open Bio (2013) 0.82
Functional significance of the discordance between transcriptional profile and left ventricular structure/function during reverse remodeling. JCI Insight (2016) 0.78
Applications of different weighting schemes to improve pathway-based analysis. Comp Funct Genomics (2011) 0.77
Propofol improves recovery of the isolated working hypertrophic heart from ischaemia-reperfusion. Pflugers Arch (2012) 0.77
Abrogation of Nrf2 impairs antioxidant signaling and promotes atrial hypertrophy in response to high-intensity exercise stress. J Transl Med (2016) 0.76
Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility. J Cardiovasc Transl Res (2016) 0.75
Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers. Trends Cardiovasc Med (2016) 0.75
Methods in molecular cardiology: microarray technology. Neth Heart J (2003) 0.75
Effects of acute and chronic sunitinib treatment on cardiac function and calcium/calmodulin-dependent protein kinase II. Br J Pharmacol (2015) 0.75
Polycystin 2-dependent cardio-protective mechanisms revealed by cardiac stress. Pflugers Arch (2017) 0.75
Three TF Co-expression Modules Regulate Pressure-Overload Cardiac Hypertrophy in Male Mice. Sci Rep (2017) 0.75
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (1995) 88.48
Exploring the metabolic and genetic control of gene expression on a genomic scale. Science (1997) 60.15
Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci U S A (1999) 39.79
The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19
Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet (1996) 15.73
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A (1999) 14.16
DNA arrays for analysis of gene expression. Methods Enzymol (1999) 12.50
The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics (1996) 11.71
Gene expression profile of aging and its retardation by caloric restriction. Science (1999) 8.06
Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA (1996) 4.31
Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J (1991) 3.29
"Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res (1998) 2.30
Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation (1998) 2.05
The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem (1997) 1.80
Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation (1998) 1.58
Gene expression analysis by transcript profiling coupled to a gene database query. Nat Biotechnol (1999) 1.50
Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am J Physiol (1994) 1.46
Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med (Berl) (1998) 1.37
Electrical stimulation of neonatal cardiomyocytes results in the sequential activation of nuclear genes governing mitochondrial proliferation and differentiation. Proc Natl Acad Sci U S A (1997) 1.29
Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. Am J Med Sci (1999) 1.28
Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: III. Intercalated disc remodeling. J Mol Cell Cardiol (1999) 1.25
Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest (1995) 1.24
Atrial natriuretic peptide in chronic heart failure in the rat: a correlation with ventricular dysfunction. Circ Res (1986) 1.23
Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice. Br J Pharmacol (1999) 1.20
Transcription of early developmental isogenes in cardiac myocyte hypertrophy. J Mol Cell Cardiol (1989) 1.02
Alterations in atrial and plasma atrial natriuretic factor (ANF) content during development of hypoxia-induced pulmonary hypertension in the rat. Proc Soc Exp Biol Med (1986) 1.00
Expression of Id1 results in apoptosis of cardiac myocytes through a redox-dependent mechanism. J Biol Chem (1998) 0.96
Catecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression. J Mol Med (Berl) (1998) 0.93
C-myc protooncogene modulates cardiac hypertrophic growth in transgenic mice. Am J Physiol (1992) 0.92
Myosin heavy chain mRNA during the development and regression of myocardial hypertrophy. Eur Heart J (1984) 0.91
Insulin-like growth factors and insulin increase the contractility of neonatal rat cardiocytes in vitro. Basic Res Cardiol (1989) 0.89
Modulation of cardiac hypertrophy by estrogens. Adv Exp Med Biol (1997) 0.87
Cardiac hypertrophy: old concepts, new perspectives. Mol Cell Biochem (1997) 0.83
Prognostic significance of left ventricular hypertrophy regression. Adv Exp Med Biol (1997) 0.83
Vasopressin signaling pathways in vascular smooth muscle. Front Biosci (1998) 0.82
Cardiac catechol O-methyltransferase and monoamine oxidase activity in congestive heart failure. Am J Physiol (1968) 0.81
Antagonism of the renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. Methods Find Exp Clin Pharmacol (1999) 0.81
Immediate postnatal rat heart development modified by abdominal aortic banding: analysis of gene expression. Mol Cell Biochem (1997) 0.80
[Molecular mechanisms of myocardial hypertrophy and deterioration]. Kardiologiia (1983) 0.79
Hypertrophic responses of cardiomyocytes induced by endothelin-1 through the protein kinase C-dependent but Src and Ras-independent pathways. Hypertens Res (1999) 0.79
Central vasopressin in experimental aortic stenosis in the rat. Cardiovasc Res (1995) 0.79
Differential expression and localization of annexin V in cardiac myocytes during growth and hypertrophy. Mol Cell Biochem (1998) 0.79
Hemodynamics and mitochondrial energy metabolism in right heart hypertrophy after acute hypoxic stress. Arzneimittelforschung (1999) 0.79
F1-ATP synthase beta-subunit and cytochrome c transcriptional regulation in right ventricular hemodynamic overload and hypertrophically stimulated cardiocytes. J Mol Cell Cardiol (1999) 0.78
Endothelin-1 stimulates hypertrophy and contractility of neonatal rat cardiac myocytes in a serum-free medium. II. J Cardiovasc Pharmacol (1991) 0.78
VISTA : visualizing global DNA sequence alignments of arbitrary length. Bioinformatics (2000) 12.50
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell (1992) 10.97
Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science (2000) 10.14
An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science (2001) 8.73
Active conservation of noncoding sequences revealed by three-way species comparisons. Genome Res (2000) 6.18
Genomic strategies to identify mammalian regulatory sequences. Nat Rev Genet (2001) 5.78
Microarray expression profiling identifies genes with altered expression in HDL-deficient mice. Genome Res (2000) 4.95
Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A (1990) 4.40
Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science (1997) 4.25
Detection of sickle cell anaemia and thalassaemias. Nature (1987) 3.94
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron (1999) 3.50
Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol Lett (1996) 3.40
Mapping the Burkholderia cenocepacia niche response via high-throughput sequencing. Proc Natl Acad Sci U S A (2009) 3.16
Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev Biol (1998) 3.16
Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat Genet (1997) 2.81
Deletion of a coordinate regulator of type 2 cytokine expression in mice. Nat Immunol (2001) 2.62
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet (1997) 2.56
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med (2001) 2.50
Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci U S A (1998) 2.32
Atherogenesis in transgenic mice expressing human apolipoprotein(a) Nature (1992) 2.28
Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg (2000) 2.13
Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol (2007) 2.12
Molecular characterization of a surface protein antigen gene from serotype c Streptococcus mutans, implicated in dental caries. Mol Microbiol (1989) 2.11
Cloning of a surface protein antigen gene from serotype c Streptococcus mutans. Mol Microbiol (1989) 2.07
Influence of dentition status on physical disability, mental impairment, and mortality in institutionalized elderly people. J Dent Res (2001) 2.06
Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis (1999) 2.03
Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest (1994) 1.93
Release of Ca2+ from a non-mitochondrial store site in peritoneal macrophages treated with saponin by inositol 1,4,5-trisphosphate. Biochem J (1984) 1.92
Inhibition of macrophage migration by muramyl peptides. Infect Immun (1979) 1.91
Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol (1995) 1.89
Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem (1999) 1.85
Biological function of the dTDP-rhamnose synthesis pathway in Streptococcus mutans. J Bacteriol (1997) 1.80
The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: the Hisayama study. J Dent Res (2004) 1.80
Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plant arum and analogous synthetic compounds. J Immunol (1976) 1.76
Affinity and specificity of the interactions between Streptococcus mutans antigen I/II and salivary components. J Dent Res (1994) 1.75
Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region. Genome Res (1997) 1.69
Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res (1992) 1.66
Construction of a series of pACYC-derived plasmid vectors. Gene (1995) 1.64
Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature (1993) 1.62
Identification of two distinct NADH oxidases corresponding to H2O2-forming oxidase and H2O-forming oxidase induced in Streptococcus mutans. J Gen Microbiol (1993) 1.61
Positive and negative regulation of epicardial-mesenchymal transformation during avian heart development. Dev Biol (2001) 1.58
Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast. J Allergy Clin Immunol (1999) 1.57
Biochemical and immunobiological properties of lipopolysaccharide (LPS) from Bacteroides gingivalis and comparison with LPS from Escherichia coli. Infect Immun (1985) 1.55
Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery (2000) 1.55
Inhibition of macrophage migration by synthetic muramyl dipeptide. Biochem Biophys Res Commun (1978) 1.53
Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem (2000) 1.52
Putative inositol 1,4,5-trisphosphate binding proteins in rat brain cytosol. J Biol Chem (1992) 1.51
Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine. Hum Gene Ther (1998) 1.50
Relationship between upper body obesity and periodontitis. J Dent Res (2001) 1.49
Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis. Antimicrob Agents Chemother (1994) 1.49
Sonographic features of colon carcinoma seen with high-frequency transabdominal ultrasound. J Clin Ultrasound (1994) 1.46
The adjuvant activity of a non-toxic, water-soluble glycopeptide present in large quantities in the culture filtrate of Mycobacterium tuberculosis strain DT. Immunology (1975) 1.45
Simple and rapid detection of Streptococcus mutans and Streptococcus sobrinus in human saliva by polymerase chain reaction. Oral Microbiol Immunol (2000) 1.44
Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice. Proc Natl Acad Sci U S A (1994) 1.42
Adult reversible cardiomyopathy with pituitary adrenal insufficiency caused by empty sella--a case report. Angiology (2000) 1.41
Sucrose-dependent cell adherence and cariogenicity of serotype c Streptococcus mutans. J Gen Microbiol (1986) 1.40
A comparative study of once-a-day morning and once-a-day bedtime administration of 40 mg famotidine in treating gastric ulcers. Am J Gastroenterol (1992) 1.39
Identification of a fourth gene involved in dTDP-rhamnose synthesis in Streptococcus mutans. J Bacteriol (1997) 1.35
Role of T lymphocytes in adjuvant arthritis. I. Evidence for the regulatory function of thymus-derived cells in the induction of the disease. J Immunol (1976) 1.34
The vibrator mutation causes neurodegeneration via reduced expression of PITP alpha: positional complementation cloning and extragenic suppression. Neuron (1997) 1.32
Genes involved in cell wall localization and side chain formation of rhamnose-glucose polysaccharide in Streptococcus mutans. J Bacteriol (1998) 1.30
Regeneration of myocardial phosphocreatine in pigs despite continued moderate ischemia. Circ Res (1990) 1.30
Formalin fixed brains are useful for magnetic resonance imaging (MRI) study. J Neurol Sci (1987) 1.29
Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus. Proc Natl Acad Sci U S A (1989) 1.28
Induction of the early growth response (Egr) family of transcription factors during thymic selection. J Exp Med (1997) 1.28
Immunochemical and structural characterization of a serotype-specific polysaccharide antigen from Actinobacillus actinomycetemcomitans Y4 (serotype b). Infect Immun (1989) 1.27
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue. Nat Genet (1995) 1.27
Immunogenicity and protective effect against oral colonization by Streptococcus mutans of synthetic peptides of a streptococcal surface protein antigen. J Immunol (1991) 1.26
Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc Natl Acad Sci U S A (2000) 1.26
Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. Clin Cancer Res (2000) 1.26
Heat-shock protein 60: implications for pathogenesis of and protection against bacterial infections. Immunol Rev (1991) 1.26
A novel gene required for rhamnose-glucose polysaccharide synthesis in Streptococcus mutans. J Bacteriol (1999) 1.26
Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr Res (2000) 1.26
Characterization of a cell-surface protein antigen of hydrophilic Streptococcus mutans strain GS-5. J Gen Microbiol (1989) 1.25
Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother (1993) 1.25
Macrophage colony-stimulating factor and interleukin-1 alpha maintain the survival of osteoclast-like cells. Endocrinology (1995) 1.24
Role of T lymphocytes in adjuvant arthritis. II. Different subpopulations of T lymphocytes functioning in the development of the disease. J Immunol (1978) 1.24
Biological functions of UDP-glucose synthesis in Streptococcus mutans. Microbiology (1998) 1.24
Purification and characterization of cell-associated glucosyltransferase synthesizing water-insoluble glucan from serotype c Streptococcus mutans. J Gen Microbiol (1989) 1.24
Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol (2003) 1.24
Patterns for RANTES secretion and intercellular adhesion molecule 1 expression mediate transepithelial T cell traffic based on analyses in vitro and in vivo. J Exp Med (1998) 1.22
Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice. J Lipid Res (1994) 1.22
Peyer's patches are required for oral tolerance to proteins. Proc Natl Acad Sci U S A (2001) 1.21
Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus. Immunity (1997) 1.20
The Ehlers-Danlos syndrome: on beyond collagens. J Clin Invest (2001) 1.19
Homology between surface protein antigen genes of Streptococcus sobrinus and Streptococcus mutans. FEBS Lett (1989) 1.19
Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I. J Biol Chem (1997) 1.19
Polyarthritis induced in the rat with cell walls from several bacteria and two Streptomyces species. Proc Soc Exp Biol Med (1973) 1.18
Virulence factors of Streptococcus mutans and dental caries prevention. J Dent Res (1984) 1.18
Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype. Hum Mol Genet (1996) 1.17
Formation of methyl mercaptan from L-methionine by Porphyromonas gingivalis. Infect Immun (2000) 1.16
Active downregulation of myocardial energy requirements during prolonged moderate ischemia in swine. Circ Res (1991) 1.16
ARHGEF9 disruption in a female patient is associated with X linked mental retardation and sensory hyperarousal. J Med Genet (2007) 1.16
Acute joint inflammation in mice after systemic injection of the cell wall, its peptidoglycan, and chemically defined peptidoglycan subunits from various bacteria. Infect Immun (1985) 1.16
In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J Clin Invest (1995) 1.15
Saliva-binding region of Streptococcus mutans surface protein antigen. Infect Immun (1993) 1.15
Immunogenicity and arthritogenicity in the rat of an antigen from Mycobacterium tuberculosis wax D. J Immunol (1973) 1.15
Classification of Vibrio bacteriophages. Intervirology (1984) 1.14